BK7502 Cannabis Concept
Market Closed 05-03 16:00:00 AEST
245.23
+2.73
+1.13%
High
248.78
Low
241.11
Vol
11.14M
Open
242.96
D1 Closing
242.50
Amplitude
3.16%
Mkt Cap
0.00
Tradable Cap
0.00
Total Shares
0.00
T/O
1.08M
T/O Rate
--
Tradable Shares
0.00
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Atlas Pearls (ASX:ATP) Is Very Good At Capital Allocation
Simply Wall St. · 05-04 05:24
Atlas Pearls (ASX:ATP) Is Very Good At Capital Allocation
Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger
The Market Herald · 05-02 08:06
Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger
Could ASX cannabis shares be set for a smoking hot rebound?
MotleyFool · 05-01
Could ASX cannabis shares be set for a smoking hot rebound?
We're Keeping An Eye On Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate
Simply Wall St. · 05-01
We're Keeping An Eye On Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate
Little Green Pharma continues to shine in a paddock of pot stock weeds
Informed Investor · 04-29
Little Green Pharma continues to shine in a paddock of pot stock weeds
BRIEF-Bod Science Says Now Entered Doca With Biortica In Accordance With Doca Proposal
Reuters · 04-26
BRIEF-Bod Science Says Now Entered Doca With Biortica In Accordance With Doca Proposal
Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%
Simply Wall St. · 04-25
Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%
Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M
The Market Herald · 04-23
Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M
BRIEF-Emyria Receives Bids Of A$2.3M To Expand Clinical Services
Reuters · 04-23
BRIEF-Emyria Receives Bids Of A$2.3M To Expand Clinical Services
BRIEF-Althea Group Announces Distribution Agreement With Symbion
Reuters · 04-22
BRIEF-Althea Group Announces Distribution Agreement With Symbion
Load more
Introduction
Company Name.
BK7502
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"BK7502","market":"AU","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":245.23389,"timestamp":1714715970107,"preClose":242.50272,"halted":0,"volume":11143978,"delay":0,"changeRate":0.011262,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":2.731171,"latestTime":"05-03 16:00:00 AEST","open":242.96344,"high":248.77557,"low":241.10635,"amount":1081518,"amplitude":0.031625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1714953600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1714694400000,1714716000000]],"turnoverRate":0.001426,"increases":3,"decrements":3,"flats":9,"marketCap":965421219.625,"floatMarketCap":552514387.625},"requestUrl":"/m/hq/s/BK7502","defaultTab":"news","newsList":[{"id":"2432616868","title":"Atlas Pearls (ASX:ATP) Is Very Good At Capital Allocation","url":"https://stock-news.laohu8.com/highlight/detail?id=2432616868","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2432616868?lang=en_us&edition=fundamental","pubTime":"2024-05-04 05:24","pubTimestamp":1714771464,"startTime":"0","endTime":"0","summary":"Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4131000-choice2-main-header/1585186733037","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4131000-choice2-main-header/1585186733037"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-durables/asx-atp/atlas-pearls-shares/news/atlas-pearls-asxatp-is-very-good-at-capital-allocation","is_publish_highlight":false,"gpt_icon":0},{"id":"2432661986","title":"Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger","url":"https://stock-news.laohu8.com/highlight/detail?id=2432661986","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2432661986?lang=en_us&edition=fundamental","pubTime":"2024-05-02 08:06","pubTimestamp":1714608360,"startTime":"0","endTime":"0","summary":"Overnight, the Democratic Biden government did something sure to give their counterparts counterpoints – the USA downgraded the risk profile it gives cannabis.Cannabis, or marijuana, is now a ‘schedule 3’ drug in the US, which caused a run up in the stock prices of some US cannabis stocks – at least one ETF jumped some 25%.ASX-listed Little Green Pharma has also released news on the move today – not too long after Germany made weed legal wholemeal.The US Drugs Enforcement Agency will ultimately oversee the changes to America’s justice system where related to cannabis charges.The implication the market is hearing is – perhaps predictably – that this will translate into less regulation and control over medicinal cannabis products.LGP did note on Thursday however that the US Department of Health and Human Services had suggested the DEA wind back the intensity of its anti-cannabis stance back in 2023.It’s also an election year, and the Democrats are scrambling to secure young voters – pa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/little-green-pharma-closely-eyeing-usas-legal-downgrade-of-cannabis-danger-2024-05-02/","is_publish_highlight":false,"gpt_icon":0},{"id":"2432561763","title":"Could ASX cannabis shares be set for a smoking hot rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2432561763","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2432561763?lang=en_us&edition=fundamental","pubTime":"2024-05-01 09:43","pubTimestamp":1714527784,"startTime":"0","endTime":"0","summary":"Moving cannabis to a less onerous drug classification would lower taxes on pot stocks and could also encourage more US states to legalise it, offering a growing legal market. It would also help cannabis companies in the US to access banking services. Dan Ahrens, managing director of Advisorshares Investments said , \"There's been a lot of rumours coming out in the last few days, but this looks official…I think it makes it easier for the House and Senate to act on SAFER Banking.\" And, as Jefferies analystOwen Bennettnotes, a reclassification by the DEA could see more institutional investment flow into the sector. While that would likely be more beneficial to American listed stocks, ASX cannabis shares could enjoy some welcome tailwinds from this shift. \"The major reason current multiples are depressed is lack of institutional ownership,\" Bennett said. He added that the DEA's move: Would hugely improve the prospects of full federal legalisation within the next five years, with a cr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/01/could-asx-cannabis-shares-be-set-for-a-smoking-hot-rebound/","is_publish_highlight":false,"gpt_icon":0},{"id":"2432530446","title":"We're Keeping An Eye On Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2432530446","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2432530446?lang=en_us&edition=fundamental","pubTime":"2024-05-01 06:14","pubTimestamp":1714515249,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. By way of example, Botanix Pharmaceuticals has seen its share price rise 156% over the last year, delighting many shareholders. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.In light of its strong share price run, we think now is a good time to investigate how risky Botanix Pharmaceuticals' cash burn is. In this article, we define cash burn as its annual free cash flow, which is the amount of money a company spends each year to fund its growth. First, we'll determine its cash runway by comparing its cash burn with its cash reserves.How Is Botanix Pharmaceuticals' Cash Burn Changing Over Time?Since it has a market capitalisation of AU$347m,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/were-keeping-eye-botanix-pharmaceuticals-221409269.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431885688","title":"Little Green Pharma continues to shine in a paddock of pot stock weeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2431885688","media":"Informed Investor","top":-1,"share":"https://ttm.financial/m/news/2431885688?lang=en_us&edition=fundamental","pubTime":"2024-04-29 10:23","pubTimestamp":1714357382,"startTime":"0","endTime":"0","summary":"The uptake of medicinal cannabis products in Australia continues to boom, but most providers of the herbaceous material are not reaping the benefits because of oversupply, commoditised pricing and investor indifference.","market":null,"thumbnail":"https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/debb6629f87bac85f19375a1181d8e4868ac47d0.jpg","type":0,"news_type":0,"thumbnails":["https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/debb6629f87bac85f19375a1181d8e4868ac47d0.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.sharecafe.com.au/2024/04/29/little-green-pharma-continues-to-shine-in-a-paddock-of-pot-stock-weeds/","is_publish_highlight":false,"gpt_icon":0},{"id":"2430273749","title":"BRIEF-Bod Science Says Now Entered Doca With Biortica In Accordance With Doca Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2430273749","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2430273749?lang=en_us&edition=fundamental","pubTime":"2024-04-26 20:05","pubTimestamp":1714133143,"startTime":"0","endTime":"0","summary":"April 26 - Bod Science : * ON 8 APRIL, CREDITORS OF BOD RESOLVED TO ACCEPT A DEED OF COMPANY ARRANGEMENT AS PROPOSED BY BIORTICA AGRIMED * NOW ENTERED INTO A DOCA WITH BIORTICA IN ACCORDANCE WITH DOCA PROPOSAL * CO WILL REMAIN IN SUSPENSION THROUGHOUT DEED ADMINISTRATION PROCESSFurther company coverage: ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430496032","title":"Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430496032","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2430496032?lang=en_us&edition=fundamental","pubTime":"2024-04-25 04:37","pubTimestamp":1713991074,"startTime":"0","endTime":"0","summary":"Ecofibre Limited ( ASX:EOF ) shareholders that were waiting for something to happen have been dealt a blow with a 39...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-eof/ecofibre-shares/news/ecofibre-limited-asxeof-might-not-be-as-mispriced-as-it-look","is_publish_highlight":false,"gpt_icon":0},{"id":"2429135643","title":"Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M","url":"https://stock-news.laohu8.com/highlight/detail?id=2429135643","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2429135643?lang=en_us&edition=fundamental","pubTime":"2024-04-23 10:42","pubTimestamp":1713840120,"startTime":"0","endTime":"0","summary":"ASX-listed and WA-based Emyria Limited has announced its successful receipt of commitments for $2.3M in funding to expand its clinical services intended to treat medication-resistant PTSD with MDMA and similar compounds.Capital raisings of any kind aren’t typically smiled upon by shareholders, reflected in today’s -1.8% decline of the EMD share price to 5.5c in lunchtime trades.The company highlighted on Tuesday that its Chair, Greg Hutchinson, has subscribed for $0.3M. Total C-suite participation clocked in at $320,000.All in all, the company seeks to use the funds to expand its clinical services. Those clinical services are, ultimately, the product of a partnership with University of Western Australia chemists.Those chemists have developed a range of ‘MDMA-like compounds’ for use in treating patients with PTSD who have not responded well to traditional methodologies for that condition.The emerging field of science – if you want to use the word ’emerging’ – has long been of interest","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/emyria-locks-in-2-3m-to-progress-mdma-research-with-chair-adding-0-3m-2024-04-23/","is_publish_highlight":false,"gpt_icon":0},{"id":"2429318104","title":"BRIEF-Emyria Receives Bids Of A$2.3M To Expand Clinical Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2429318104","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429318104?lang=en_us&edition=fundamental","pubTime":"2024-04-23 09:24","pubTimestamp":1713835494,"startTime":"0","endTime":"0","summary":"April 23 (Reuters) - Emyria Ltd : * EMYRIA RECEIVES BIDS OF A$2.3M TO EXPAND CLINICAL SERVICES * PLACEMENT AT A$0.05 EACH SHAREFurther company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429965680","title":"BRIEF-Althea Group Announces Distribution Agreement With Symbion","url":"https://stock-news.laohu8.com/highlight/detail?id=2429965680","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429965680?lang=en_us&edition=fundamental","pubTime":"2024-04-22 09:08","pubTimestamp":1713748086,"startTime":"0","endTime":"0","summary":"April 22 (Reuters) - Althea Group Holdings Ltd : * ANNOUNCES DISTRIBUTION AGREEMENT WITH SYMBION * AGREEMENT FOR DISTRIBUTION OF PORTFOLIO OF PHARMACEUTICAL CANNABIS PRODUCTS ACROSS AUSTRALIAFurther company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0276},{"period":"3month","weight":0.0615},{"period":"6month","weight":0.1142},{"period":"1year","weight":0.1069},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7502","nameEN":"BK7502"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cannabis Concept(BK7502),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cannabis Concept(BK7502) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cannabis Concept,BK7502,Cannabis Concept股票,Cannabis Concept股票老虎,Cannabis Concept股票老虎国际,Cannabis Concept行情,Cannabis Concept股票行情,Cannabis Concept股价,Cannabis Concept股市,Cannabis Concept股票价格,Cannabis Concept股票交易,Cannabis Concept股票购买,Cannabis Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cannabis Concept(BK7502),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cannabis Concept(BK7502) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}